An NIAID treatment study seeks individuals ages 18 to 75 who have been diagnosed with rheumatoid arthritis (RA). The primary purpose of this study is to determine the effectiveness of two tumor necrosis factor (TNF)-blocking agents on memory B lymphocytes in the peripheral blood of participants with RA.
Research teams for this study are located at the following locations:
University of Alabama, Birmingham
University of California, San Francisco
University of Chicago
Feinstein Institute for Medical Research, Manhassett, NY
University of Rochester
Medical University of South Carolina, Charleston
Read more about the study and contact a study location on clinicaltrials.com.
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis - Full Text View - ClinicalTrials.gov
%201.53.45%E2%80%AFp.m..png)
No hay comentarios:
Publicar un comentario